Characterization of novel modifiers of dE2F/RBF function
Characterization of novel modifiers of dE2F/RBF function
批准号:
7778250
负责人:
Maxim Frolov
金额:
$26.09万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-04-01 至 2012-03-31
关键词:
AffectAnimal ModelAnimalsApoptosisBiologicalCell CycleCell Cycle ProgressionCell Cycle RegulationCell DeathCell ProliferationCell divisionCellsChromosomesChromosomes, Human, Pair 3ComplementComplexDataDefectDevelopmentDrosophila genusE2F transcription factorsFaceFamilyFamily memberGene ExpressionGene TargetingGenesGenetic ScreeningGenetic TranscriptionGenomeGoalsHomologous GeneHumanMalignant NeoplasmsMammalian CellMapsModelingMolecularMutationPathway interactionsPhasePhenotypePlayProteinsReadingReagentRegulationRepressionResearchRetinoblastomaRetinoblastoma GenesRetinoblastoma ProteinRight-OnRoleScreening procedureTranscription CoactivatorTumor SuppressionTumor Suppressor Proteinsarmbasecell growthflyin vivointerestmutantneoplastic cellnovelnumb proteinresearch studytumorigenesis
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The retinoblastoma protein (pRB) is an important tumor suppressor that functions as a negative regulator of cell proliferation by restraining the activity of the E2F transcription factor. The E2F transcription factor is a critical regulator of the G1 to S transition and its activity is rate-limiting for S phase entry. In most tumor cells, the pRB pathway is believed to be functionally inactivated; this highlights the significance of pRB and E2F in the regulation of mammalian cell proliferation. While the critical role of pRB and E2F is well established, how precisely these proteins regulate cell cycle progression, what these proteins do, and why their activities are " so important, is not completely understood. Adding to the problem, there is an increasing number of proteins which have been shown to interact with pRB. Currently, the field faces a major challenge to identify the interactions which are functionally significant for pRB function. The proposed research aims to take advantage of Drosophila as a model organism to identify important regulators of endogenous E2F/RBF represser activity. In Drosophila, there are two E2F genes. dE2F1 is a strong activator of transcription and positive regulator of cell proliferation. During larval development, its activity is counterbalanced by the represser dE2F2. Our approach is based on our previous finding, that the strong block in cell proliferation in de2f1 mutants is due to the unchecked activity of the dE2F2/RBF represser complex. We propose to perform a genetic screen for mutations which suppress the de2f1 mutant phenotype. These mutations may be in genes whose products are functionally important for dE2F2/RBF to block cell cycle in vivo. Two specific aims are proposed: (1) To perform a full scale screen for suppressors of the de2f1 mutant phenotype on the right arm of chromosome 3, and to develop strategies for and to initiate screening of, other autosomal arms. (2) To carry out a detailed phenotypic analysis and mapping of suppressors of the de2f1 mutant phenotype. Our goal is to identify functional partners of the dE2F2/RBF represser complex which are critical for dE2F2/RBF- dependent block in cell proliferation in vivo. Given the pivotal role of pRB in tumor suppression, an understanding of how the function of the Drosophila homologues dE2F2/RBF is regulated will provide crucial clues in understanding the regulation of mammalian cell growth and the ways in which such controls may go wrong in human cancer.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Control of cell proliferation and differentiation by the Retinoblastoma tumor suppressor pathway
-
批准号:10396992
-
项目类别:
-
资助金额:$57.02万
-
财政年份:2019
-
负责人:Maxim Frolov
-
依托单位:
Control of cell proliferation and differentiation by the Retinoblastoma tumor suppressor pathway
-
批准号:10794727
-
项目类别:
-
资助金额:$3.4万
-
财政年份:2019
-
负责人:Maxim Frolov
-
依托单位:
Control of cell proliferation and differentiation by the Retinoblastoma tumor suppressor pathway
-
批准号:10611940
-
项目类别:
-
资助金额:$57.02万
-
财政年份:2019
-
负责人:Maxim Frolov
-
依托单位:
Control of cell proliferation and differentiation by the Retinoblastoma tumor suppressor pathway
-
批准号:9908112
-
项目类别:
-
资助金额:$57.02万
-
财政年份:2019
-
负责人:Maxim Frolov
-
依托单位:
Functional interaction between the mir11~998 intronic microRNA cluster and Retinoblastoma tumor suppressor pathway
-
批准号:8991496
-
项目类别:
-
资助金额:$31.97万
-
财政年份:2015
-
负责人:Maxim Frolov
-
依托单位:
Functional interaction between the mir11~998 intronic microRNA cluster and Retinoblastoma tumor suppressor pathway
-
批准号:8816779
-
项目类别:
-
资助金额:$31.96万
-
财政年份:2015
-
负责人:Maxim Frolov
-
依托单位:
Genetic integration of pRB and Hippo tumor suppressor pathways
-
批准号:8319369
-
项目类别:
-
资助金额:$29.65万
-
财政年份:2011
-
负责人:Maxim Frolov
-
依托单位:
Genetic integration of pRB and Hippo tumor suppressor pathways
-
批准号:8708116
-
项目类别:
-
资助金额:$29.65万
-
财政年份:2011
-
负责人:Maxim Frolov
-
依托单位:
Rb and Hippo tumor suppressor pathways in differentiation
-
批准号:9355642
-
项目类别:
-
资助金额:$33.58万
-
财政年份:2011
-
负责人:Maxim Frolov
-
依托单位:
Genetic integration of pRB and Hippo tumor suppressor pathways
-
批准号:8019364
-
项目类别:
-
资助金额:$28.46万
-
财政年份:2011
-
负责人:Maxim Frolov
-
依托单位:
Genetic integration of pRB and Hippo tumor suppressor pathways
-
批准号:8514010
-
项目类别:
-
资助金额:$28.62万
-
财政年份:2011
-
负责人:Maxim Frolov
-
依托单位:
Characterization of novel modifiers of dE2F/RBF function
-
批准号:8054279
-
项目类别:
-
资助金额:$25.83万
-
财政年份:2007
-
负责人:Maxim Frolov
-
依托单位:
Characterization of novel modifiers of dE2F/RBF function
-
批准号:7195896
-
项目类别:
-
资助金额:$26.35万
-
财政年份:2007
-
负责人:Maxim Frolov
-
依托单位:
Characterization of novel modifiers of dE2F/RBF function
-
批准号:7351791
-
项目类别:
-
资助金额:$26.35万
-
财政年份:2007
-
负责人:Maxim Frolov
-
依托单位:
Characterization of novel modifiers of dE2F/RBF function
-
批准号:7589721
-
项目类别:
-
资助金额:$26.35万
-
财政年份:2007
-
负责人:Maxim Frolov
-
依托单位:
海外基金